Carregant...
Fitxers
Tipus de document
ArticleData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/162044
Efficacy and safety of ossein-hydroxyapatite complex versus calcium carbonate to prevent bone loss
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Objective: This study aimed to compare the efficacy and safety of ossein-hydroxyapatite complex (OHC) versus calcium carbonate (CC) for preventing bone loss during perimenopause in current clinical practice.Methods: The prospective, comparative, non-randomized, open-label study included 851 perimenopausal women with basal bone mineral density (BMD) T-score ≥-2 standard deviations (SDs). Participants received either OHC (712 mg calcium/day) or CC (1000 mg calcium/day) over 3 years. BMD was evaluated by dual-energy X-ray absorptiometry at the lumbar spine (L2-L4) at baseline and after 18 and 36 months of follow-up. Adverse drug reactions (ADRs) were also recorded.Results: In women receiving OHC, BMD at the L2-L4 site remained stable over the 3-year follow-up period (mean [SD] change 0.00 [0.11] g/cm2). BMD in the CC arm decreased -3.1% (mean [SD] - 0.03 [0.11] g/cm2). Between-group differences were statistically significant (p < 0.001) and favored OHC. ADRs were more frequent in the CC group (7.7% vs. 2.7% in the OHC group; p = 0.001), affecting primarily the gastrointestinal system.Conclusion: OHC showed greater efficacy and tolerability than CC for bone loss prevention in perimenopausal women in real-world practice. As the daily dose of calcium was higher in the CC group, the differences might be linked to the ossein compound in OHC.
Matèries
Matèries (anglès)
Citació
Citació
CASTELO-BRANCO FLORES, Camil, CANCELO HIDALGO, M. j., PALACIOS RUIZ, Lucas santiago, CIRIA RECASENS, M., FERNÁNDEZ PAREJA, A., CARBONELL ABELLA, Cristina, MANASANCH, J., HAYA PALAZUELOS, J.. Efficacy and safety of ossein-hydroxyapatite complex versus calcium carbonate to prevent bone loss. _Climacteric_. 2020. Vol. 23, núm. 3, pàgs. 252-258. [consulta: 21 de gener de 2026]. ISSN: 1369-7137. [Disponible a: https://hdl.handle.net/2445/162044]